Regulación 29/02 - Cecmed - Infomed

BIBLIOGRAFÍA1. Requisitos para las solicitudes de Inscripción, Renovación y Modificación en elRegistro de Medicamentos de uso Humano, 2 000.2. Lineamientos de la OMS para Evaluación de Medicamentos Herbarios. Juana Mejíade Rodríguez. CYTED. 2da. Reunión de Coordinación Internacional de la RedIberoamericana de Productos Fitofarmacéuticos (Riprofito). Pág 41.3. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirtyfourthreport of the WHO Expert Committee. Geneva, World Health Organization, 1996( WHO Technical Report Series, No. 863).4. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Twentyninthreport. Geneva, World Healt Organization, 1984 ( WHO Technical Report Series,No. 704).5. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirtysecondreport. Geneva, World Healt Organization, 1992 ( WHO Technical ReportSeries, No. 823).6. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirtythirdreport. Geneva, World Healt Organization, 1993 ( WHO Technical Report Series,No. 834).7. Legislación en Iberoamérica sobre Fitofármacos y Productos Naturales/ MildredGarcía González, editor: Armando Cáceres. -1.ed.- San José, C. R. : Editorial de laUniversidad de Costa Rica: CYTED, 2000. 396p.8. Regulation on Tradicional Medicine: European Experience. Hubertus Cranz. CYTED.Memoir of Section VI. Standardización, Quality Control and Registration of HerbalMedicinal Products. Pág 79. I Grupo de Trabajo EAMIPreparados a base de Plantas Medicinales. Fitofármacos.10. Working Group on the Safety and Efficacy of Herbal Medicine. Repert series No.:RS/92/GE/15 (PHL).11. Draft Guideline on the format and content of applications for designation as orphanmedicinal products, revision 18/4/00.12. Final proposals for Revision of the Note for Guidance on Quality of Herbal Remedies.Emea. 1998.